TP53 and familial pancreatic carcinoma: In addition to the expected KRAS mutations, which occur early in pancreatic cancer’s development and are found in more than 90% of pancreatic tumors, mutations were most frequently observed in the tumor suppressor genes MLH1, TP53 and APC, as well as the oncogenes Notch1 and BRAF.